Hormone-release inhibiting peptides aldosterone antagonists

All categories
DBCAT005386Pharmacologic class

What you can answer from here — as of February 04, 2021

1SubcategoryNarrower classes within this one
Sign in

Which Hormone-release inhibiting peptides aldosterone antagonists are approved where, and how do their indications and safety profiles compare?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In